FDA launches PreCheck program to bring drug manufacturing back to US

The program seeks to boost regulatory predictability, support construction of US-based manufacturing sites

Carbogen Amcis Shanghai site receives drug manufacturing license from Chinese NMPA

CDSCO and State Drugs Control Administration commence joint inspection of drug manufacturing units

A committee of two Joint Drugs Controllers has been constituted at CDSCO to monitor the process of inspection, reporting, and subsequent action to ensure compliance to the Drugs & Cosmetics Act, 1940

Aizon partners with TetraScience to help pharma companies speed up drug manufacturing efficiently

The partnership demonstrates increasing adoption of tetra data to create unrestricted innovation

ASU drug manufacturing licence goes online

The applicants will only have to get their Good Manufacturing Practices certification validated every five years to retain their licence

Lonza to expand its drug manufacturing network in Switzerland

Lonza, a global manufacturing partner to the pharma, biotech and nutrition industries, has announced it will invest in additional drug product manufacturing capabilities in Switzerland

Gujarat Themis Biosyn acquires MicroBiopharm Japan for Rs. 1,300 Cr

Transition to a fermentation-based globally integrated CDMO platform

Indoco Remedies' Baddi plant gets EU GMP approval from Malta Medicines Authority

The certification follows an inspection conducted by the Malta Medicines Authority between January 29, 2026, and February 3, 2026

AI will eliminate 70-80% of current pharma commercial processes: Dushyant Sapre, Founder and CEO, SwishX

We are building an AI-native operating system for pharma sales and distribution

CARBOGEN AMCIS Shanghai site clears unannounced NMPA GMP inspection

Successful inspection outcome strengthens company’s regulatory compliance and manufacturing standards in China